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ABSTRACT Ueda and Suzuki (1998. Biochim. Biophys. Acta. 1380:313–319; 1998. Biophys. J. 75:1052–1057) reported that
myristic acid inhibited firefly luciferase in M range in competition with luciferin, whereas anesthetics inhibited it in millimeter
ranges noncompetitively with luciferin. Myristate increased, whereas anesthetics decreased, the thermal denaturation
temperature. The present study showed that high pressure increased the steady-state light intensity of the halothane-doped
firefly luciferase but decreased that of the myristate-doped firefly luciferase. The steady-state light intensity showed a
maximum at 19.1°C. At 19.1°C, high pressure did not affect the light intensity in the absence of the inhibitors. In the presence
of 0.5 mM halothane, however, 25 MPa pressure (maximum effect) increased the light intensity to 106.0% of the control
without the inhibitor. In the presence of 2.5 M myristate, 40 MPa pressure decreased the light intensity to 90.9% of the
control. When the temperature was 25°C in the absence of inhibitors, 40 MPa pressure increased the light intensity 119.2%
of the ambient value. At 0.5 mM halothane, 40 MPa pressure further increased the light intensity to 106.1% above the control
40 MPa value. At 2.5 M myristate, 40 MPa pressure decreased the light intensity to 90.1% of the control 40 MPa value. From
the pressure dependence of the light intensity, the volume change V of the enzyme was estimated at 25°C: 0.5 mM
halothane increased V  3.93 cm3 mol1, whereas 2.5 M myristate decreased V  7.66 cm3 mol1. Present results
show that there are distinct differences between the specific and nonspecific ligands in their response to high pressure.
Myristate, which competes with luciferin, decreased the protein volume and stabilized the conformation against thermal
perturbation. Halothane, which does not compete with the substrate, increased the protein volume and destabilized the
conformation.
INTRODUCTION
The first report that firefly luciferase was highly sensitive to
anesthetics appeared more than three decades ago (Ueda,
1965). Subclinical concentrations of volatile anesthetics in-
hibited partially purified cell-free enzyme from Japanese
firefly (Luciola cruciata). Later, Ueda and Kamaya (1973),
reporting on the temperature dependence of the anesthetic
effects on partially purified American firefly luciferase
(Photinus pyralis), concluded that anesthetics inhibited the
enzyme by reversibly denaturing the structure into the less
active unfolded form. The H of anesthetic interaction with
the protein was about 370 kJ mol1. Dickinson et al. (1993)
argued that the binding H of anesthetics to firefly lucif-
erase was smaller and negative, about 20 kJ mol1. How-
ever, their small negative value represents the transfer of
anesthetic molecules ( 100–200 Da) from water to firefly
luciferase. Our large positive value represents the transfer of
firefly luciferase (62,000 Da) from water to anesthetic
solutions.
With differential scanning calorimetry, Chiou and Ueda
(1994) reported that the thermal denaturation of firefly
luciferase occurred at about 41°C with Hcal of 415 kJ
mol1. Two luciferin competitors, anilinonaphthalenesul-
fonate and toluidinonaphthalenesulfonate (DeLuca, 1969),
increased the thermal denaturation temperature, whereas
ethanol decreased it (Chiou and Ueda, 1994). Ueda and
Suzuki (1998a,b) reported that myristate is three orders of
magnitude stronger than volatile anesthetics and alcohols as
an inhibitor of firefly luciferase. The Lineweaver-Burk plot
at a steady-state condition showed that myristate inhibited
firefly luciferase in competition with luciferin, whereas
anesthetics did not. Luciferin is a heterocyclic carboxylate.
The initial reaction of firefly luciferase is to activate lucife-
rin by ATP to form acylAMP. Activation of fatty acids by
acylCoA synthetases also involves activation of fatty acids
by ATP to form acylAMP. Homology between these en-
zymes has been reported (Suzuki et al., 1990; Babbitt et al.,
1992; Ye et al., 1997). It is not surprising that myristate
competes with luciferin.
Moss et al. (1991) reported that application of high pres-
sure did not affect the initial flash intensity of firefly lucif-
erase. In contrast, Ueda et al. (1994) reported that high
pressure decreased the steady-state light intensity at low
temperatures but increased it at high temperatures. The
discrepancy between Moss et al. (1991) and Ueda et al.
(1994) was caused by the difference in the choice of pa-
rameters to represent the reaction velocity: initial flash
intensity versus steady-state light intensity.
In ordinal enzyme kinetics, the rate is expressed by the
amount of product accumulated in a unit of time. Because
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light intensity does not accumulate, the light intensity is
equivalent to the differential of the ordinal enzyme reaction.
The rapid reaction kinetics of the transition state theory
(Hiromi, 1979) shows that when the rate of the first reaction
in a multiple-stage reaction is faster than the rate of the final
reaction, there is a rapid accumulation of the product of the
first reaction. The rapid accumulation of the first product is
designated a pre-steady-state burst. When the product accu-
mulation is differentiated with regard to time, the initial
rapid accumulation of the product is represented by a peak,
equivalent to the initial flash intensity of firefly luciferase.
Firefly luciferase is a typical multiple-stage enzyme with
three substrates, luciferin, ATP, and oxygen, interacting
with the enzyme at different stages (McElroy and Seliger,
1962; DeLuca and McElroy, 1974, 1978).
E ATP Luciferin^ E  LuciferylAMP PPi
E  LuciferylAMP O2 3 E  OxyluciferylAMP Light
E  OxyluciferylAMP 3 E Oxyluciferin AMP
E Oxyluciferin ATP^ E  OxyluciferylAMP PPi
where PPi is pyrophosphate. The first reaction is the pro-
duction of photon, and the third reaction is the release of
oxyluciferin from the enzyme. In the accompanying article
(Ueda et al., 1999), the stopped-flow study showed that the
initial peak intensity represents the concentration of the
active enzyme and is unrelated to reaction kinetics. The present
study compared effects of high pressure up to 40 MPa on the
inhibitory effects of myristate and halothane. The steady-state
condition was obtained by eliminating the initial peak with
addition of pyrophosphate (McElroy and Seliger, 1962; Ueda
et al., 1994; Ueda and Suzuki, 1998a,b).
MATERIALS AND METHOD
Lyophilized crystalline firefly luciferase from P. pyralis, D-luciferin, ATP,
glycylglycine, and pyrophosphate were purchased from Sigma (St. Louis,
MO), halothane from Imperial Chemical (New York, NY), and methanol
from EM Science (Cherry Hill, NJ).
Steady-state light intensity was obtained by decelerating the initial
reaction with addition of pyrophosphate. Firefly luciferase was dissolved in
100 mM glycylglycine buffer, pH 7.8, at 20 g ml1. The firefly luciferase
solution contained 100 M luciferin, 10 mM MgSO4, and 50 mM pyro-
phosphate, to which 5 mM ATP in the glycylglycine buffer was added.
The mixture was rapidly transferred to an Aminco high-pressure cell
with sapphire windows (Silver Spring, MD). The cell was covered by a
water jacket and the temperature was controlled by circulating water from
a water bath. The cell temperature was monitored by a filament thermistor
inserted into a small hole in the pressure block and a Digitech thermometer
(United Systems, Dayton, OH) with 0.01°C resolution. The cell was
pressurized with hexane via a separator. Pressure was monitored by an
Autoclave Engineers model DPS-0201 transducer (Erie, PA) with 1.0 psi
(0.07 bar) resolution.
The light intensity was measured by a Hitachi-Perkin-Elmer 139 UV-
Visible spectrophotometer (Norwalk, CT). The sample compartment was
replaced by the high-pressure cell. The photomultiplier output and the
pressure-transducer output were recorded in a Nicolet 310 Digital Record-
ing Oscilloscope (Madison, WI). The data were downloaded on floppy
disks and analyzed by Origin software (Microcal, Northampton, MA).
RESULTS
The temperature scan of the steady-state light intensity of
firefly luciferase showed that the maximum light intensity was
observed at 19.1°C. When pressurized at the temperature that
gave maximum light, hydrostatic pressure did not show any
effect in the absence of inhibitors. The results agreed with our
previous report (Ueda et al., 1994). When halothane was
added, pressure increased the light intensity with a maximum
effect at about 25 MPa (Fig. 1). Further increase of pressure
decreased the light intensity to the control. At the halothane
concentrations of 0.01, 0.05, 0.1, 0.25, and 0.5 mM, 25 MPa
pressure increased the steady-state light intensity to 101.1,
102.2, 103.2, 104.5, and 106.0% of the control, respectively.
Fig. 2 shows the pressure effect on the steady-state light
intensity in the presence of myristate at 19.1°C. Application
of hydrostatic pressure in the presence of myristate de-
creased the light intensity monotonously and no minimum
was observed, in contrast to the observed effect of halo-
thane. At the myristate concentrations of 0.01, 0.25, 0.5, 1.0,
and 2.5 M, 40 MPa pressure decreased the steady-state
light intensity to 98.9, 96.9, 95.1, 93.2, and 90.9% of the
control, respectively.
Fig. 3 shows the pressure effect on the steady-state light
intensity at 25°C. At this temperature, 40 MPa pressure
increased the steady-state light intensity 119.2% of the
control at ambient pressure (0.1 MPa) in the absence of the
inhibitors. Application of hydrostatic pressure in the pres-
ence of halothane further increased the steady-state light
intensity monotonously without a maximum. At halothane
concentrations of 0.01, 0.05, 0.1, 0.25, and 0.5 mM, 40 MPa
pressure increased the steady-state light intensity, respec-
tively, to 101.4, 102.5, 103.6, 104.9, and 106.1% of the
control without the anesthetic at 40 MPa. Fig. 4 shows the
pressure effect on the myristate inhibition at 25°C. At the
myristate concentrations of 0.05, 0.25, 0.5, 1.0, and 2.5 M,
40 MPa pressure decreased the steady-state light intensity to
98.6, 96.5, 94.4, 92.4, and 90.1% of the control, respectively.
FIGURE 1 Effect of hydrostatic pressure at 19.1°C on the steady-state
light intensity in the presence of halothane. Ordinate is the relative light
intensity, taking the values at ambient pressure 100. Abscissa is the applied
hydrostatic pressure in MPa. The lines are (from the bottom): control,
halothane 0.01, 0.05, 0.1, 0.25, and 0.5 mM. The pressure effect on
halothane showed a maximum at about 19°C.
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There are two reference states (controls) to express the
pressure effects on the light intensity of the ligand-bound
firefly luciferase: first, the light intensity at the same pres-
sure in the absence of inhibitors; second, the light intensity
at ambient pressure in the presence of inhibitors. The ac-
companying article expressed the pressure effect according
to the second criterion. When compared with halothane-
inhibited steady-state light intensity at ambient pressure, 40
MPa pressure increased the steady-state light intensity
120.9, 122.1, 123.5, 125.0, and 126.4% of the control,
respectively. Similarly, when compared with the myristate-
inhibited light intensity at ambient pressure, 40 MPa pres-
sure increased the light intensity to 117.1, 114.6, 112.1,
109.7, and 107.5% of the control, respectively. These in-
crements are smaller than the control.
From the pressure effects on the light intensities of the
control and the inhibitor-bound luciferase, the volume
changes of the host protein were estimated. The Johnson-
Eyring rate-process model calculates the V by plotting the
logarithm of the ratio between the inhibitor-induced decre-
ment of the light intensity and the control light intensity
against the applied pressure (Appendix). Fig. 5 shows the
Johnson-Eyring plot of 0.5 mM halothane at 25°C. From
this slope, the V was estimated to be 3.94 cm3 mol1.
Fig. 6 is the plot of 2.5 M myristate at 25°C. The V was
7.66 cm3 mol1.
DISCUSSION
Application of high pressure clearly distinguished the com-
petitive inhibitors from the noncompetitive inhibitors. Pres-
sure antagonized the effect of the nonspecific inhibitor,
whereas it enhanced the effect of the competitive inhibitor.
At the temperature that gave the maximum light intensity,
hydrostatic pressure did not affect the light intensity. Even
at this temperature, high pressure antagonized the effect of
the noncompetitive inhibitor, halothane, on the steady-state
luminescence, whereas it intensified that of the competitive
inhibitor, myristate.
FIGURE 5 The Johnson-Eyring plot at 25°C for 0.5 mM halothane.
Ordinate is the logarithm of (I1/I2 - 1)(1  1/K1), where I1 is the steady-
state light intensity of the control, I2 is the light intensity in the presence of
halothane, and K1 is the equilibrium constant between the native and
reversibly unfolded states of firefly luciferase (Appendix). Abscissa is the
applied hydrostatic pressure in MPa.
FIGURE 2 Effect of hydrostatic pressure at 19.1°C on the steady-state
light intensity in the presence of myristate The lines are (from the top):
control, myristate 0.01, 0.25, 0.5, 1.0, and 2.5 M. The pressure effect on
myristate inhibition was monotonous, without minimum or maximum, and
decreased the light intensity.
FIGURE 3 Effect of hydrostatic pressure at 25°C on the steady-state
light intensity in the presence of halothane. The lines are (from the bottom):
control without inhibitor, halothane 0.01, 0.05, 0.1, 0.25, and 0.5 mM. The
pressure effect on halothane became monotonous and increased the light
intensity.
FIGURE 4 Effect of hydrostatic pressure at 25°C on the steady-state
light intensity in the presence of myristate The lines are (from the top):
control without inhibitor, myristate 0.01, 0.25, 0.5, 1.0, and 2.5 M. The
pressure effect on myristate inhibition was monotonous, without minimum
or maximum, and decreased the light intensity.
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Eyring (1966) proposed the rate-process theory according
to which nonspecific binders (anesthetics and alcohols) in-
teract with enzymes by nonspecific hydrophobic effect and
reversibly unfold the enzyme. Koshland (1958, 1963) pro-
posed the induced-fit theory, according to which the specific
binding of substrates to enzymes induces the enzyme con-
formation into the high-energy transition state. We also
found that the effects of specific and nonspecific binders on
the physical properties of the host protein are reverse. Chiou
and Ueda (1994) and Ueda and Suzuki (1998a,b) showed
that the luciferin competitors increased the thermal denatur-
ation temperature of firefly luciferase. Catanzano et al.
(1997) also showed that D-glucose increased the denatur-
ation temperature of yeast hexokinase B. DeLuca and Marsh
(1967) showed that oxyluciferylAMP is a strong luciferin
competitor and protected firefly luciferase from thermal
inactivation. In contrast, the nonspecific inhibitors of firefly
luciferase, anesthetics and alcohols, decreased the thermal
denaturation temperature (Chiou and Ueda, 1994; Ueda and
Suzuki, 1998a,b). Velicelebi and Sturtevant (1979) showed
that alcohols decreased the thermal denaturation tempera-
ture of lysozyme.
The present study showed that myristate decreased the
volume of firefly luciferase, whereas halothane increased
the volume. By solution densimetry, Ueda and Mashimo
(1982) showed that anesthetics expanded the partial molal
volume of bovine serum albumin. The transition state, pro-
posed by Koshland (1958, 1963), resists thermal denatur-
ation and has compact conformation compared to the native
state. The unfolded state has expanded conformation and
lower thermal denaturation temperature. These results dem-
onstrate that anesthetics and alcohols are nonspecific con-
formation destabilizers, whereas specific binders are con-
formation stabilizers.
To our knowledge, all reports but one on the anesthetic
actions on enzymes concluded they are allosteric effects.
The only exception, concluding that anesthetics compete
with substrates (Franks and Lieb, 1984), was based on use
of the Lineweaver-Burk plots on the pre-steady-state flash
intensity and is therefore incorrect. Aside from the use of
the nonsteady state in analyzing the inhibition kinetics, the
use of the Lineweaver-Burk plot to determine multiple-
stage reactions requires justification for the applicability of
the linearization procedure. The reaction rate law of enzyme
action is highly complicated, as described by the classical
theory of King and Altman (1956) and by the recent theory
of Roussel and Fraser (1993). In addition to the complexity
of the rate law, there are a number of intermediate states
between the luciferin binding and the light emission: bind-
ing of ATP, binding of O2, oxidation of luciferin, deproto-
nation, transition to the excited state, energy release by
returning to the ground state, and release of the final prod-
uct, oxyluciferin, from the enzyme. Anesthetics and alco-
hols may act at any one of these stages. Even if the plot
shows apparent competition, the exact binding mode may
not be established. The Lineweaver-Burk plot determines
only whether or not the inhibition is surmountable by the
infinite increase of the substrate concentration. Its indis-
criminate use leads to erroneous conclusions.
At present, the idea that anesthetics and alcohols bind to
a specific receptor is widely accepted without clear defini-
tion of specificity and nonspecificity. Specific binding
means that a specific compound interacts with a specific
receptor on a specific protein. Acetylcholine does not bind
to -aminobutyric acid receptors no matter how much the
concentration is increased. Also, -aminobutyric acid does
not bind to acetylcholine receptors. The neurotransmitters
are specific binders. Anesthetics affect -aminobutyric acid
receptors, acetylcholine receptors, and all other signal trans-
duction systems and channels when the concentration is
increased. They are nonspecific binders; therefore, anesthet-
ics inhibit bacterial luciferase as well. Myristate is a specific
inhibitor. Therefore, it does not inhibit bacterial luciferase.
Instead, myristate activated the dark mutant of bacterial
luciferase (Ulitzur and Hastings, 1978).
As a rule, specific binders are characterized by high
affinity and small binding numbers, whereas nonspecific
TABLE 1 The effect of hydrostatic pressure on the steady-
state light intensity of firefly luciferase, inhibited by halothane
or myristate, at 19.1 and 25.0°C
Halothane (mM)
0.01 0.05 0.10 0.25 0.50
19.1°C* 101.1 102.2 103.2 104.5 106.0
25.0°C† 101.4 102.5 103.6 104.9 106.1
Myristate (M)
0.10 0.25 0.5 1.0 2.5
19.1°C* 98.9 96.9 95.1 93.2 90.9
25.0°C† 98.6 96.5 94.4 92.4 90.1
The values are expressed as a percent of the control at the same pressure
without the ligands.
*Pressurized at 25 MPa, where the pressure effects were maximum.
†Pressurized at 40 MPa.
FIGURE 6 The Johnson-Eyring plot at 25°C for 2.5 M myristate.
Ordinate is the logarithm of (I1/I2 - 1), where I1 is the steady-state light
intensity of the control, I2 is the light intensity in the presence of myristate.
Because the activity of the competitive inhibitors does not depend on
unfolding, the (1  1/K1) term is not included (see Appendix).
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binders are characterized by low affinity and large binding
numbers. Anesthetics fit well within the concept of nonspe-
cific ligands. For example, Yoshida et al. (1997) reported
that the weak binding of halothane to bovine serum albumin
was associated with KD 10.9 mM and the maximum binding
number, Bmax, of 34.5 by
19F-NMR. The effects of specific
ligands on firefly luciferase temperature and pressure are un-
ambiguously the reverse of the effects of nonspecific ligands.
The strong hydrophobicity of the luciferin binding site
(DeLuca, 1969) makes it possible to find anesthetic mole-
cules at the site. Nevertheless, they do not interact with the
luciferin receptor. There is a major difference between residing
at the receptor site and interacting with the receptor. The
surface of a protein is composed of hydrophobic and hydro-
philic sites. These sites must be occupied by either solvent or
cosolvent. Anesthetics are nonspecific hydrophobic binders
and interact with all accessible hydrophobic sites on proteins.
Ueda and Suzuki (1998a,b) have shown that the effects of
anesthetics are highly cooperative with Hill numbers above
unity. The Hill number does not indicate the actual number of
ligands that bind to the host molecule. The derivation assumes
highly cooperative interaction between enzyme (E) and ligand
(L) where only two species are present, E and ELn. The
intermediates, EL1, EL2, . . . , ELn-1, are not counted. When the
Hill number exceeds one, at least two ligand molecules bind to
the host molecule. Therefore, the Hill number is often called
the cooperativity parameter. We maintain that anesthetics act
by cooperative actions at multiple sites, rather than interaction
with a single specific site.
This study was supported by the U. S. Department of
Veterans Affairs’ medical research funds.
Appendix
We (Ueda and Suzuki, 1998a,b) reported that myristic acid inhibited firefly
luciferase by competing with the substrate luciferin. Conversely, anesthet-
ics inhibited firefly luciferase noncompetitive with luciferin, and by chang-
ing the equilibrium constant, K1, between the unfolded inactive fraction
and native fraction.
We designate X and r as the concentration and the number, respectively,
of bound competitive inhibitors. U and s are, respectively, the concentra-
tion and the number of bound allosteric inhibitors. K2 and K3 are the
association constants of the competitive and noncompetitive inhibitors,
respectively. I1 and I2 are the light intensity of the control and the inhibitor-
bound firefly luciferase, respectively.
Because myristate inhibits firefly luciferase by competing with luciferin
and not by thermal inactivation, the ratio of the light intensities of firefly
luciferase in the absence (I1) and presence (I2) of myristate is expressed
according to the Johnson-Eyring rate-process theory (Ueda et al., 1994):
I1
I2
 1 K2X	
lnI1I2 1 r lnX ln K2 r lnX G0,2RT  pV2RT
Anesthetics inhibit the enzyme by changing the equilibrium constant,
K1, of the unfolded inactive fraction and native fraction.
lnI1I2 11 1K1 s ln U ln k3
 s ln U
G0,3
RT

pV3
RT
where subscript 0 signifies zero applied pressure and subscripts 2 and 3 are
the properties related to myristate and anesthetics, respectively.
The V values are estimated by plotting the left-hand side against the
applied pressure.
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